Abstract:The role of the metalloproteinase ADAMTS4 in the generation of N‐terminally elongated Aβ peptide species has been characterized with cell‐free and cell‐based assays in combination with mass spectrometry. Immunohistochemical analysis revealed the deposition of N‐terminally elongated Ab variants in the brains of a subset of AD patients. Aims The aggregation and deposition of amyloid‐β (Aβ) peptides in the brain is thought to be the initial driver in the pathogenesis of Alzheimer's disease (AD). Aside from full‐length Aβ peptides starting with an aspartate residue in position 1, both N‐terminally truncated and elongated Aβ peptides are produced by various proteases from the amyloid precursor protein (APP) and have been detected in brain tissues and body fluids. Recently, we demonstrated that the particularly abundant N‐terminally truncated Aβ4–x peptides are generated by ADAMTS4, a secreted metalloprotease that is exclusively expressed in the oligodendrocyte cell population. In this study, we investigated whether ADAMTS4 might also be involved in the generation of N‐terminally elongated Aβ peptides. Methods We used cell‐free and cell‐based assays in combination with matrix‐assisted laser desorption/ionisation time‐of‐flight mass spectrometry (MALDI‐TOF) and electrochemiluminescence sandwich immunoassays to identify and quantify N‐terminally elongated Aβ peptide variants. Antibodies against these Aβ variants were characterised by peptide microarrays and employed for the immunohistochemical analyses of human brain samples. Results In this study, we discovered additional ADAMTS4 cleavage sites in APP. These were located N‐terminal to Asp‐(1) in the Aβ peptide sequence between residues Glu‐(‐7) and Ile‐(‐6) as well as Glu‐(‐4) and Val‐(‐3), resulting in the release of N‐terminally elongated Aβ‐6‐x and Aβ‐3‐x peptides, of which the latter serve as a component in a promising Aβ‐based plasma biomarker. Aβ‐6/‐3‐40 peptides were detected in supernatants of various cell lines and in the cerebrospinal fluid (CSF), and ADAMTS4 enzyme activity promoted the release of Aβ‐6/‐3‐x peptides. Furthermore, by immunohistochemistry, a subset of AD cases displayed evidence of extracellular and vascular localization of N‐terminally elongated Aβ‐6/‐3‐x peptides. Discussion The current findings implicate ADAMTS4 in both the pathological process of Aβ peptide aggregation and in the early detection of amyloid pathology in AD.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Structural biology of cell surface receptors implicated in Alzheimer’s disease

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Identification and characterization of C-terminal fragments of the beta-amyloid precursor produced in cell culture.

The amyloid hypothesis of Alzheimer's disease at 25 years

Intraneuronal Abeta42 accumulation in human brain.

Mechanism of the Cleavage Specificity of Alzheimer'S Disease Gamma-Secretase Identified by Phenylalanine-Scanning Mutagenesis of the Transmembrane Domain of the Amyloid Precursor Protein

Aβ42 and Aβ40: similarities and differences.

Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease

Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

Advances in the β-amyloid precursor protein of Alzheimer's disease

Endoplasmic Reticulum and Trans-Golgi Network Generate Distinct Populations of Alzheimer Beta-Amyloid Peptides

Nonfibrillar Diffuse Amyloid Deposition Due To A Gamma(42)-Secretase Site Mutation Points To An Essential Role For N-Truncated A Beta(42) In Alzheimer'S Disease

Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

Current hypotheses of Alzheimer disease neuropathology and dementia

Aβ*56 is present in brain extracts enriched for extracellular proteins

Distribution of f 3 / A 4 Protein and Amyloid Precursor Protein in Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch Type and Alzheimer ' s Disease

Construction of Drug Screening Cell Model and Application to New Compounds Interfering Production and Accumulation of Beta-Amyloid by Inhibiting Gamma-Secretase

[Cloning and Expression of Human Single-Chain Fv Antibody Against Amyloid Beta Peptide Involved in Alzheimer's Disease].

Comparison Of Neurotoxicity Of Different Aggregated Forms Of A Beta 40, A Beta 42 And A Beta 43 In Cell Cultures